AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PRO MEDICUS LTD

166.870

+0.3600.22%

Volume:193.94K

Turnover:32.29M

Market Cap:17.44B

PE:65.80

High:167.750

Open:165.000

Low:162.750

Close:166.510

52wk High:320.003

52wk Low:107.225

Shares:104.51M

Float Shares:52.96M

Volume Ratio:1.10

T/O Rate:0.37%

Dividend:0.69

Dividend Rate:0.41%

EPS(TTM):2.536

EPS(LYR):2.536

ROE:74.97%

ROA:25.84%

PB:38.68

PE(LYR):65.80

Loading ...

Overview Company News Filings

Australia's Pro Medicus Hits Near Three-Week Low on Trading Ex-Dividend

Founder Led Stocks With Long Term Alignment Investors Should Watch

Simply Wall St.

3 Founder Led Australian Stocks Built For Higher Rates

Simply Wall St.

Pro Medicus (ASX:PME) Is Up 10.0% After EPS Jump And Dividend Hike Has The Bull Case Changed?

Simply Wall St.

Pro Medicus (ASX:PME) Tests Its Valuation Narrative On Annual Results And Dividend

Simply Wall St.

Pro Medicus' Unit Signs AU$25 Million Contract With US Health System

MT Newswires Live

Pro Medicus - Rollout to Commence Immediately with Go-Live Targeted for Q1 2027

THOMSON REUTERS

Pro Medicus Limited - Contract is for Visage 7 Viewer, Visage 7 Workflow, Visage 7 Open Archive and Visage 7 Cardiology Imaging.

THOMSON REUTERS

Pro Medicus Limited - Signs 7-Year, a$25M Contract with Valley Health

THOMSON REUTERS

Pro Medicus (ASX:PME) Shares Command Perfection As Non Cash Profit Concerns Linger

Simply Wall St.

Pro Medicus Has Proven Quality but Its Stock Isn't Cheap

Australian Stocks Hold Steady

Pro Medicus' Busiest Year for Implementations Provides 'Strong Momentum' Heading Into Fiscal 2027, Jefferies Says

MT Newswires Live

Australia's Pro Medicus Hits Near One-Month High on Profit Beat

Pro Medicus Fiscal 2026 Underlying Earnings, Revenue Up

MT Newswires Live

Pro Medicus Limited-CEO Interview FY26 Results

THOMSON REUTERS

Pro Medicus Ltd FY Revenue AUD 261.7 Million

THOMSON REUTERS

Pro Medicus Signs Convertible Note Agreement With Echo IQ to Execute Commercial Partnership Deal

MT Newswires Live

Pro Medicus Limited - Signs A$23 Mln Contract with St. Luke's Health System

THOMSON REUTERS

Should Pro Medicus’ 7-Year, Usage-Based St. Luke’s Deal Require Action From ASX:PME Investors?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/PME.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PME.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","market":"AU","secType":"STK","nameCN":"PRO MEDICUS LTD","latestPrice":166.87,"timestamp":1789020720000,"preClose":166.51,"halted":0,"volume":193944,"delay":0,"changeRate":0.0021620323103718315,"nameEN":"PRO MEDICUS LTD","floatShares":52960584,"shares":104510839,"eps":2.535999,"marketStatus":"Not Yet Opened","change":0.36,"latestTime":"09-10 16:12:00 AEST","open":165,"high":167.75,"low":162.75,"amount":32289154,"amplitude":0.030028,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.535999,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":166.51,"dividendRate":0.004135,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":1.1014088476848762,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PME.AU","preClose":166.87,"auctionPrice":166.51,"auctionVolume":50,"auctionTime":1789079281181,"referenceTime":1789036203090,"auction":1,"marketStatus":"盘前竞价","timestamp":1789079281181}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","floatShares":52960584,"roa":"25.84%","roe":"74.97%","lyrEps":2.535999,"volumeRatio":1.1014088476848762,"shares":104510839,"dividePrice":0.69,"high":167.75,"amplitude":0.030028,"preClose":166.51,"low":162.75,"week52Low":107.225,"pbRate":"38.68","psRate":"66.64","week52High":320.003,"institutionHeld":0,"latestPrice":166.87,"eps":2.535999,"divideRate":0.004135,"volume":193944,"delay":0,"ttmEps":2.535999,"open":165,"prevYearClose":219.793,"prevWeekClose":173.58,"prevMonthClose":179.008,"prevQuarterClose":202.997,"fiveDayClose":172.333,"twentyDayClose":183.319,"sixtyDayClose":167.253,"dividendPayoutRate":0.24411995739713002,"dividendGrowthYears":7,"dividendGrowthRate":0.31914893617021284,"fiveYearAvgDividendRate":0.0030617859399975815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PME.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-07","symbol":"PME.AU","amount":0.37,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-08","defaultRemindTime":1788739200000,"name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-08","currency":"AUD","dateTimestamp":1788703200000,"payDate":"2026-09-29"},{"date":"2026-08-18","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-02-26","symbol":"PME.AU","amount":0.32,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-02-27","name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-02-27","currency":"AUD","dateTimestamp":1772024400000,"payDate":"2026-03-20"},{"date":"2026-02-12","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770850800000,"name":null,"time":"","dateTimestamp":1770814800000,"actualEps":null},{"date":"2025-09-03","symbol":"PME.AU","amount":0.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-04","defaultRemindTime":1756857600000,"name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-25","payableDate":"2025-09-04","currency":"AUD","dateTimestamp":1756821600000,"payDate":"2025-09-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PME.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-02","value":0.06,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-19","value":0.07,"currency":"AUD"},{"executeDate":"2021-09-09","recordDate":"2021-09-10","paymentDate":"2021-10-01","value":0.08,"currency":"AUD"},{"executeDate":"2022-03-03","recordDate":"2022-03-04","paymentDate":"2022-03-25","value":0.1,"currency":"AUD"},{"executeDate":"2022-09-08","recordDate":"2022-09-09","paymentDate":"2022-09-30","value":0.12,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PME.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665395665","title":"Australia's Pro Medicus Hits Near Three-Week Low on Trading Ex-Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2665395665","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665395665?lang=en_us&edition=fundamental","pubTime":"2026-09-07 10:30","pubTimestamp":1788748225,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Pro Medicus hits near three-week low on trading ex-dividend** Shares of Australia's Pro MedicusPME.AXfall as much as 3.4% to A$168.00, their lowest since August 18** Stock logs its worst session since September 2** Healthcare informatics firm tradesex-dividend; distributes a final dividend of A$0.37 per share** PME down 22.9% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL6N44Z03U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002013","title":"Founder Led Stocks With Long Term Alignment Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002013","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002013?lang=en_us&edition=fundamental","pubTime":"2026-08-31 23:22","pubTimestamp":1788189735,"startTime":"0","endTime":"0","summary":"With central banks signaling that interest rates may stay higher for longer, investors face a tougher backdrop for companies that rely on cheap capital and short term momentum. Founder led businesses often take a different path. Leaders with significant skin in the game tend to think in decades, not quarters. This article highlights 3 founder led stocks from our screener that show how this ownership mindset can shape long term opportunity.\nThe three founder led stocks in this article are only...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-maq/macquarie-technology-group-shares/news/founder-led-stocks-with-long-term-alignment-investors-should","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-maq/macquarie-technology-group-shares/news/founder-led-stocks-with-long-term-alignment-investors-should","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BK7043","BK7094","BK7042","BK7067","MQG.AU","ISBC","PME.AU","MAQ.AU","BK7501","BK7046","BK7511","BK4211","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663721010","title":"3 Founder Led Australian Stocks Built For Higher Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2663721010","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663721010?lang=en_us&edition=fundamental","pubTime":"2026-08-30 01:17","pubTimestamp":1788023852,"startTime":"0","endTime":"0","summary":"Central banks are hinting that interest rates could stay higher for longer as inflation pressures persist. That kind of backdrop tends to reward leaders who think and act like long term owners. Founder led companies often fit that profile, with executives whose own wealth is tied to what you care about: long term equity value. This article highlights 3 founder led stocks from our screener that show how that mindset looks in practice.\nThe three founder led stocks in this article are just a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-maq/macquarie-technology-group-shares/news/3-founder-led-australian-stocks-built-for-higher-rates","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-maq/macquarie-technology-group-shares/news/3-founder-led-australian-stocks-built-for-higher-rates","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7043","DACE.AU","MSB.AU","IIGF.AU","BK7501","IOZ.AU","BK7067","OZR.AU","BK7094","PME.AU","IMLC.AU","BK7511","EIGA.AU","GEAR.AU","SLF.AU","IISV.AU","QFN.AU","VAS.AU","MQG.AU","ZYAU.AU","E200.AU","BK7042","STW.AU","XKO.AU","BEAR.AU","BBOZ.AU","OZF.AU","VAP.AU","XAO.AU","BK7046","BK7508","XJO.AU","QRE.AU","MAQ.AU","GIVE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662220728","title":"Pro Medicus (ASX:PME) Is Up 10.0% After EPS Jump And Dividend Hike Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662220728","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662220728?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:19","pubTimestamp":1787609954,"startTime":"0","endTime":"0","summary":"Pro Medicus Limited recently reported full-year 2026 results, with sales of A$261.69 million, revenue of A$270.75 million and net income of A$265.34 million, alongside sharply higher earnings per share versus the prior year.\nThe company also increased its ordinary dividend to A$0.37 per share for the year, signalling confidence in its cash generation and balance sheet strength.\nWith earnings rising strongly and the full-year dividend lifted to A$0.37, we’ll explore how this update reshapes...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/pro-medicus-asxpme-is-up-100-after-eps-jump-and-dividend-hik","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/pro-medicus-asxpme-is-up-100-after-eps-jump-and-dividend-hik","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661289215","title":"Pro Medicus (ASX:PME) Tests Its Valuation Narrative On Annual Results And Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2661289215","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661289215?lang=en_us&edition=fundamental","pubTime":"2026-08-22 10:30","pubTimestamp":1787365857,"startTime":"0","endTime":"0","summary":"Pro Medicus (ASX:PME) is in focus after reporting full year 2026 earnings, with sales of A$261.69 million, revenue of A$270.75 million and net income of A$265.34 million, alongside announcing an ordinary dividend of A$0.37 per share.\nSee our latest analysis for Pro Medicus.\nThe latest earnings and dividend news for Pro Medicus comes after a sharp 49.75% 90 day share price return and a 10.46% 30 day share price gain, although the 1 year total shareholder return has fallen 37.23%. Recent...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/pro-medicus-asxpme-tests-its-valuation-narrative-on-annual-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/pro-medicus-asxpme-tests-its-valuation-narrative-on-annual-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258261","title":"Pro Medicus' Unit Signs AU$25 Million Contract With US Health System","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258261","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258261?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:48","pubTimestamp":1787269682,"startTime":"0","endTime":"0","summary":"Pro Medicus'  Visage Imaging subsidiary signed a seven-year contract with Valley Health based in Virginia worth AU$25 million, according to a Friday filing with the Australian bourse.The new Visage contract will be implemented in the cloud and includes the \"Full Stack + 1\" plus Visage 7 Cardiology Imaging, providing a unified enterprise imaging platform, and the migration of Valley Health's legacy PACS archive to Visage 7 Open Archive, the filing said.Planning for the rollout is expected to start immediately, with the implementation slated for the first quarter of 2027, per the filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661923029","title":"Pro Medicus - Rollout to Commence Immediately with Go-Live Targeted for Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661923029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661923029?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:25","pubTimestamp":1787264747,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1HV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661296230","title":"Pro Medicus Limited - Contract is for Visage 7 Viewer, Visage 7 Workflow, Visage 7 Open Archive and Visage 7 Cardiology Imaging.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661296230","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661296230?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:25","pubTimestamp":1787264747,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1HV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661230236","title":"Pro Medicus Limited - Signs 7-Year, a$25M Contract with Valley Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2661230236","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661230236?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:25","pubTimestamp":1787264747,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660463427","title":"Pro Medicus (ASX:PME) Shares Command Perfection As Non Cash Profit Concerns Linger","url":"https://stock-news.laohu8.com/highlight/detail?id=2660463427","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660463427?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:32","pubTimestamp":1787160742,"startTime":"0","endTime":"0","summary":"Pro Medicus walked into these results with its stock already on a tear, up sharply over the past three months and closing at A$198.85 on 19 August. The market has been paying a rich multiple for perfection. The headline from this earnings release is simple: profitability remains extremely high, with net profit margin at 54.1%, yet the valuation now sits on a trailing P/E of 78.3x that leans heavily on non cash earnings.\nThat is the sentiment clash investors need to solve: enthusiasm for the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/pro-medicus-asxpme-shares-command-perfection-as-non-cash-pro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/pro-medicus-asxpme-shares-command-perfection-as-non-cash-pro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490048","title":"Pro Medicus Has Proven Quality but Its Stock Isn't Cheap","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490048","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490048?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:23","pubTimestamp":1787095380,"startTime":"0","endTime":"0","summary":"Imaging-tech provider Pro Medicus had a strong FY26 and expressed optimism about the future, but the stock doesn't look cheap to Jefferies. Pro Medicus has signaled increasing levels of wholesale adoption of its Cloud product. It also sees customers opting for all three core products--Viewer, Archive and Worklist--with its cardiology module. \"We acknowledge the proven quality of the business, but note that at a share price of circa A$200.00, our analysis suggests the market is assuming Pre Medicus will have a market share of the U.S. PACS-only market of circa 38% by FY35,\" analyst David Stanton says. That looks aggressive, he adds. Jefferies retains a hold call on Pro Medicus and raises its price target by 4.3% to A$196.40/share. Pro Medicus ended Tuesday at A$196.75.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660645247","title":"Australian Stocks Hold Steady","url":"https://stock-news.laohu8.com/highlight/detail?id=2660645247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660645247?lang=en_us&edition=fundamental","pubTime":"2026-08-18 14:36","pubTimestamp":1787034960,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Stocks in Australia were flat Tuesday, as the S&P/ASX 200 Benchmark Index held steady at 9070.00.Among local companies with a market cap of at least 15 billion Australian dollars , CSL was the biggest leader during the session, surging 17%, and Pro Medicus jumped 12%. Goodman Group rounded out the top three movers, as shares increased 3.0%.PLS Group was the biggest laggard, falling 3.1%, followed by shares of Northern Star Resources, which declined 3.1%. Shares of South32 dropped 2.0%.On the currency front, the WSJ Dollar Index rose 0.1% to 96.06. The U.S dollar strengthened 0.1% against the Australian dollar to 1.41 Australian dollars.In the bond markets, the 10-year Australian government bond yield rose 5.45 basis points to 5.077%.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PME.AU","NST.AU","BK7506","BK7094","BK7104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456028","title":"Pro Medicus' Busiest Year for Implementations Provides 'Strong Momentum' Heading Into Fiscal 2027, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456028","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660456028?lang=en_us&edition=fundamental","pubTime":"2026-08-18 11:05","pubTimestamp":1787022304,"startTime":"0","endTime":"0","summary":"Pro Medicus  saw six major renewals in fiscal 2026 amid its busiest year for implementations, with many of them occurring late in the second half of the year, giving the company \"strong momentum\" heading into fiscal 2027, Jefferies said in a Tuesday note.While the implementations did not contribute materially to fiscal 2026 revenue, Pro Medicus said they will provide a considerable step-up in transaction revenue in fiscal 2027 as the company will receive a full 12 months of revenue from the contracts.The company reported fiscal 2026 normalized EPS of AU$1.39, up around 25% from a year earlier and ahead of Jefferies' estimate of AU$1.37.The investment firm maintained a hold rating on Pro Medicus with a price target of AU$188.25.Pro Medicus shares surged 13% in recent Tuesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660545346","title":"Australia's Pro Medicus Hits Near One-Month High on Profit Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2660545346","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660545346?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:07","pubTimestamp":1787015259,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Pro Medicus hits near one-month high on profit beat** Shares of Australia's Pro MedicusPME.AXrise as much as 8.8% to A$191.28, their highest level since July 20** Stock logs biggest intraday pct gain since June 2** Healthcare informatics companyreports a 24.1% jump in underlying net profit after tax to A$144.7 million , beating Visible Alpha consensus by 2%, according to Citi** Also declares a final dividend of 35 Australian cents per share, above previous year's 30 cents per share** \"PME reported in-line sales and a 3% NPAT beat for FY26. We think this will be enough to maintain investor confidence,\" say analysts at Citi** Still, Citi says it expects recent lines of investor questioning to continue around co's ability to raise prices, sign long contracts and \"build a moat in a world where there are a range of outcomes around AI\"** YTD, stock down around 13%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4N44F015:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023251221.USD","LU0175139822.USD","LU2506951958.HKD","LU1989764748.USD","LU2265009873.SGD","LU2764263039.SGD","LU0823417653.USD","LU0971096721.USD","SG9999018865.SGD","LU0342679015.USD","BK4581","LU0158827948.USD","LU0289960550.SGD","LU2089284900.SGD","SG9999001077.SGD","LU1989772840.SGD","LU0345774631.USD","LU2764263203.CNY","LU1989773731.SGD","IAI","LU2271345857.HKD","LU1064131342.USD","LU2111349929.HKD","SG9999014906.USD","LU1989763005.USD","LU0158827781.USD","LU1989764664.SGD","LU2210150020.SGD","SGXZ31699556.SGD","BK4597","LU2506951875.HKD","LU1496350502.SGD","BK4566","LU0950375773.USD","LU2028103732.USD","SPGI","LU2506952170.USD","LU0868494617.USD","LU1804176565.USD","FDIQ","LU1363072403.SGD","LU0345774391.USD","LU1988902786.USD","PME.AU","LU2210149790.SGD","LU2720916845.USD","SG9999014880.SGD","BK4585","LU0097036916.USD","LU1989772923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660504458","title":"Pro Medicus Fiscal 2026 Underlying Earnings, Revenue Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2660504458","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660504458?lang=en_us&edition=fundamental","pubTime":"2026-08-18 08:15","pubTimestamp":1787012148,"startTime":"0","endTime":"0","summary":"Pro Medicus  logged AU$1.385 in underlying earnings per share for the fiscal 2026, compared with AU$1.116 a year ago, a Tuesday filing showed.Analysts polled by FactSet expected earnings of AU$1.40.For the 12 months ended June 30, revenue was AU$261.7 million versus AU$213 million previously, the Australia-listed healthcare informatics and technology company added. Analysts surveyed by FactSet expected AU$259.9 million.The board declared a final dividend of AU$0.37 per share, up from AU$0.30 a year earlier, payable Sept. 29 to shareholders on record as of Sept. 8.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","PME.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660430238","title":"Pro Medicus Limited-CEO Interview FY26 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660430238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660430238?lang=en_us&edition=fundamental","pubTime":"2026-08-18 07:36","pubTimestamp":1787009806,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUE8TNXNM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473430","title":"Pro Medicus Ltd FY Revenue AUD 261.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473430?lang=en_us&edition=fundamental","pubTime":"2026-08-18 07:31","pubTimestamp":1787009503,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMSM5QN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660105186","title":"Pro Medicus Signs Convertible Note Agreement With Echo IQ to Execute Commercial Partnership Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660105186","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660105186?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:40","pubTimestamp":1786927251,"startTime":"0","endTime":"0","summary":"Pro Medicus  signed a convertible note debt and option agreement with Echo IQ , representing the execution of an agreement the companies struck in June, according to a Monday filing with the Australian bourse.Under the agreement, Pro Medicus will invest up to AU$20 million in Echo IQ and become a reseller of the EchoSolv product suite across the US, an earlier filing showed.Pro Medicus' shares fell nearly 2% in recent Monday trade, while Echo IQ's shares gained nearly 3%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4552","BK4531","BK4108","IQ","BK7094","EIQ.AU","BK4505","BK7016","BK4526","PME.AU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2660103154","title":"Pro Medicus Limited - Signs A$23 Mln Contract with St. Luke's Health System","url":"https://stock-news.laohu8.com/highlight/detail?id=2660103154","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660103154?lang=en_us&edition=fundamental","pubTime":"2026-08-17 07:23","pubTimestamp":1786922604,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nFWN44C09J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PME.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659429961","title":"Should Pro Medicus’ 7-Year, Usage-Based St. Luke’s Deal Require Action From ASX:PME Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2659429961","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659429961?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:23","pubTimestamp":1786706591,"startTime":"0","endTime":"0","summary":"In August 2026, Pro Medicus announced it had secured a 7-year, A$23,000,000 contract with St. Luke’s Health System to deploy its cloud-based Visage 7 enterprise imaging platform across three US states, covering both Visage 7 Viewer and Visage 7 Workflow.\nAn interesting element of this deal is its transaction-based licensing model, which ties Pro Medicus’s revenue to actual imaging usage and creates scope for scalable income over the contract term.\nWe’ll now explore how this long-term,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/should-pro-medicus-7-year-usage-based-st-lukes-deal-require","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/should-pro-medicus-7-year-usage-based-st-lukes-deal-require","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","BK7094","PME.AU","ISBC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":138,"code":"91000000","status":"200"}]}}